David J. Woodhouse, Chief Executive Officer at NGM BIOPHARMACEUTICALS INC (NGM), sold 15,000 shares at $20.02 ($300K) on 2021-11-18, disclosed to the SEC on 2021-11-19.
Open-market sale of $300k NGM by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.